Literature DB >> 18249204

Impaired glucose tolerance is a risk factor for stroke in a Japanese sample--the Funagata study.

Toshihide Oizumi1, Makoto Daimon, Yumi Jimbu, Kiriko Wada, Wataru Kameda, Shinji Susa, Hiroshi Yamaguchi, Hiroshi Ohnuma, Makoto Tominaga, Takeo Kato.   

Abstract

Impaired glucose tolerance (IGT) is a known risk factor for cardiovascular disease, which includes stroke as well as coronary heart disease (CHD). We investigated whether IGT is a risk factor for stroke. The incidence of stroke and CHD in a cohort population (n = 2938) consisting of participants of the 1990-1997 Funagata study was assessed through interviews with the participants and their family members and reviews of death certificates and residence transfer documents through 2002. Glucose tolerance at the baseline was classified according to the criteria of the 1998 World Health Organization (normal glucose tolerance, n = 2189; IGT, n = 320; and diabetes, n = 286). The cumulative incidences among the groups were compared using the Kaplan-Meier product-limit method, and the risks of these conditions were evaluated by person-year and Cox proportional hazard methods. During the 147-month (mean, 116.5 months) follow-up, 158 (normal glucose tolerance, IGT, and diabetes: 94, 35, and 29, respectively) participants experienced a stroke and 94 (54, 16, and 24, respectively) experienced CHD. By the person-year method, IGT and diabetes were shown to be significant risk factors for stroke and CHD (odds ratio, 1.87 [95% confidence interval, 1.73-2.03] and 3.57 [3.21-3.98] for stroke; 1.53 [1.31-1.78] and 3.47 [2.91-4.14] for CHD, respectively). Cox proportional hazard analysis showed that IGT was a risk factor for stroke (age-, sex-, and hypertension-adjusted hazard ratio: 1.51 [95% confidence interval, 1.02-2.24], P = .039) but not for CHD (1.21 [0.69-2.313], .509). Impaired glucose tolerance is a risk factor for future stroke in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249204     DOI: 10.1016/j.metabol.2007.10.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

Review 1.  Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.

Authors:  Yukako Tatsumi; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

2.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

3.  Effects of barley intake on glycemic control in Japanese patients with type 2 diabetes mellitus undergoing antidiabetic therapy: a prospective study.

Authors:  Takeshi Osonoi; Tsubasa Matsuoka; Kensuke Ofuchi; Makoto Katoh; Toshiki Kobayashi; Kazuki Mochizuki
Journal:  Diabetol Int       Date:  2021-10-20

4.  Lucica MI urinary myoinositol kit: a new diagnostic test for diabetes mellitus and glucose intolerance.

Authors:  Masaru Yamakoshi; Shoji Kawazu
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 5.  Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.

Authors:  Lisa Kitasato; Taiki Tojo; Yuko Hatakeyama; Ryo Kameda; Takehiro Hashikata; Minako Yamaoka-Tojo
Journal:  Cardiovasc Diabetol       Date:  2012-06-29       Impact factor: 9.951

Review 6.  Effect of pre-diabetes on future risk of stroke: meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Keun-Sik Hong; Sarah Song; Kuo-Hsuan Chang; Bruce Ovbiagele
Journal:  BMJ       Date:  2012-06-07

7.  Effects of soybean product intake on fasting and postload hyperglycemia and type 2 diabetes in Japanese men with high body mass index: The Saku Study.

Authors:  Yukako Tatsumi; Akiko Morimoto; Kijyo Deura; Shoichi Mizuno; Yuko Ohno; Shaw Watanabe
Journal:  J Diabetes Investig       Date:  2013-05-29       Impact factor: 4.232

8.  Pro198Leu missense polymorphism of the glutathione peroxidase 1 gene might be a common genetic predisposition of distal symmetric polyneuropathy and macrovascular disease in Japanese type 2 diabetic patients.

Authors:  Shohei Matsuno; Hideyuki Sasaki; Hiroshi Yamasaki; Hiroyuki Yamaoka; Kenichi Ogawa; Muneki Nakatani; Tohru Hamanishi; Asako Doi; Yoshio Nakano; Hisao Wakasaki; Hiroto Furuta; Masahiro Nishi; Takashi Akamizu; Kishio Nanjo
Journal:  J Diabetes Investig       Date:  2011-11-30       Impact factor: 4.232

9.  Risk of proteinuria among individuals with persistent borderline diabetes: the Saku study.

Authors:  Yukako Tatsumi; Akiko Morimoto; Fumie Soyano; Tetsuo Shimoda; Naomi Miyamatsu; Yuko Ohno; Shiro Sakaguchi
Journal:  Diabetol Int       Date:  2015-09-04

10.  Assessment of metabolic status in young Japanese females using postprandial glucose and insulin levels.

Authors:  Masae Sakuma; Megumi Sasaki; Sayaka Katsuda; Kana Kobayashi; Chiaki Takaya; Minako Umeda; Hidekazu Arai
Journal:  J Clin Biochem Nutr       Date:  2014-04-12       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.